Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Swiss Biotech IPOs May Revive Industry Starved of Investment
Bloomberg
Thursday, July 7, 2011 - 10:15pm
tags:
IPOs, Roche, Novartis, Actelion, Molecular Partners, Newron Pharma, Switzerland
Amylin, Alkermes say diabetes drug safe for heart
Yahoo/AP
Thursday, July 7, 2011 - 10:13pm
tags:
diabetes, Amylin, Alkermes, Bydureon
The Good, Bad, and Ugly of Exelixis' Drug Delay
Motley Fool
Thursday, July 7, 2011 - 10:11pm
tags:
Exelixis, thyroid cancer, cabozantinib
Why the Street Should Love Endo Pharmaceuticals' Earnings
TheStreet.com
Thursday, July 7, 2011 - 7:45pm
tags:
Endo, earnings
FDA's Drug-Approval Rate for 2011 on Pace to Exceed 2010
WSJ Online
Thursday, July 7, 2011 - 7:43pm
tags:
FDA, drug approvals
Novartis' Lung Drug Cleared in US
Yahoo/Zacks.com
Thursday, July 7, 2011 - 7:41pm
tags:
Novartis, Arcapta Neohaler, COPD
Japanese Approval for Merck Products
Yahoo/Zacks.com
Thursday, July 7, 2011 - 7:40pm
tags:
Japan, Gardasil, Merck, HPV, cervical cancer, Cubicin, Cubist Pharmaceuticals
J&J's Been Busy
Motley Fool
Thursday, July 7, 2011 - 7:39pm
tags:
JNJ, HIV, Gilead Sciences, Pharmasset, hepatitis C
Big Pharma asks FDA for clear off-label rules
Fierce Pharma
Thursday, July 7, 2011 - 12:07pm
tags:
off-label, FDA, Big Pharma
Exelixis Delays Results of Cancer Drug Study
Minyanville
Thursday, July 7, 2011 - 12:06pm
tags:
Exelixis, cabozantinib, thyroid cancer
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thursday, July 7, 2011 - 12:04pm
tags:
investors, biotech, Aeterna Zentaris, YM BioSciences, Ziopharm, Oncothyreon, Seattle Genetics, Exelixis, MannKind, MELA Sciences, Neoprobe, Zalicus
Glaxo’s Avandia Is Withdrawn By New Zealand Council
Times Live, New Zealand
Thursday, July 7, 2011 - 11:48am
tags:
GSK, Avandia, diabetes, New Zealand
Zalicus: Undervalued, With Strong Pipeline Potential
Seeking Alpha
Thursday, July 7, 2011 - 11:46am
tags:
Zalicus, rheumatoid arthritis, Synavive
Transcept: Interest Rising Ahead of PDUFA Date Next Week
Seeking Alpha
Thursday, July 7, 2011 - 11:39am
tags:
Transcept, PDUFA, insomnia, Intermezzo
With Sale Of Subsidiary, It's Game Time for Apricus Biosciences
Seeking Alpha
Thursday, July 7, 2011 - 11:37am
tags:
Apricus Biosciences
Viibryd Launched by Forest Labs
Yahoo/Zacks.com
Thursday, July 7, 2011 - 11:34am
tags:
Viibryd, Forest Labs, major depressive disorder
Sanofi stops Multaq study due to safety concerns
Marketwatch
Thursday, July 7, 2011 - 11:18am
tags:
Sanofi, Multaq
Pfizer Puts Animal Health and Nutrition Businesses Up for Sale
Bloomberg
Thursday, July 7, 2011 - 11:15am
tags:
Pfizer, animal health, M&A
Lawsuit: Wyeth had illegal patents on Effexor
Yahoo/AP
Thursday, July 7, 2011 - 11:11am
tags:
Wyeth, Effexor, patents
Pfizer: The Gutted R&D Machine
Seeking Alpha
Thursday, July 7, 2011 - 11:09am
tags:
Pfizer, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.